Trevi Therapeutics
1 follower
‌
Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions.
Industries
Headquarters
Employees
Links
Org chart
Jennifer Good
Co-Founder, President & CEO
Jennifer Good
Collapse
Thomas Sciascia
Co-Founder, Chief Science Officer
Lisa Delfini
CFO
David Clark
Chief Medical Officer
Farrell Simon
Chief Commercial Officer
Katherine Takaki
VP, Global Regulatory Affairs
Katie McManus
Senior Manager, Marketing & Communications
Paula Buckley
VP, Clinical Operations
Pam Nieves
Associate Director, Quality Assurance & Compliance
Similar companies
Kyverna Therapeutics
5 followers
St. Francis Xavier Catholic School System
10 followers
UNC Charlotte
6 followers
Forge Biologics
2 followers
Vaxcyte
2 followers
Verve Therapeutics
54 followers
Ventyx Biosciences
1 follower
Edgewise Therapeutics
1 follower
nSide
3 followers
iECURE
1 follower
Twist Bioscience
8 followers
Discover companies